Literature DB >> 520345

Comparison of two different biliary agents in healthy subjects and in patients with liver disease.

R Dudczak, K Kletter, P Angelberger, H Frischauf.   

Abstract

The kinetics of the iminodiacetic acids, dimethyl and diethyl IDA were studied in patients without and with liver disease. Diethyl IDA seems to be superior to dimethyl IDA in its diagnostic usefulness. It shows lower urinary excretion and a faster liver uptake, leading to more pronounced differences in liver peak time and in liver elimination half time and to faster visualisation of the gall bladder in patients with liver disease. The enterohepatic reabsorption is negligible as shown by enteral administration of the radiopharmaceutical and monitoring blood activity. Therefore it is not necessary to correct time activity curves of the liver for the IDA secreted into the gastrointestinal system. The most valuable diagnostic information with this substances may be gained in investigations on cholecystectomized patients with cholestasis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 520345     DOI: 10.1007/BF00263305

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

Review 1.  Relationships between molecular structure and excretion of drugs.

Authors:  P Nielsen; F Rasmussen
Journal:  Life Sci       Date:  1975-11-15       Impact factor: 5.037

2.  Bile and urine as complementary pathways for the excretion of foreign organic compounds.

Authors:  P C Hirom; P Millburn; R L Smith
Journal:  Xenobiotica       Date:  1976-01       Impact factor: 1.908

3.  An evaluation of 99mTc-labeled hepatobiliary agents.

Authors:  B W Wistow; G Subramanian; R L Heertum; R W Henderson; G M Gagne; R C Hall; J G McAfee
Journal:  J Nucl Med       Date:  1977-05       Impact factor: 10.057

4.  Tissue distribution of technetium-99m and carbon-14 labeled N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic acid.

Authors:  P S Callery; W C Faith; M D Loberg; A T Fields; E B Harvey; M D Cooper
Journal:  J Med Chem       Date:  1976-07       Impact factor: 7.446

5.  Hepatobiliary radiopharmaceuticals: defining their clinical role will be a galling experience.

Authors:  P M Ronai
Journal:  J Nucl Med       Date:  1977-05       Impact factor: 10.057

6.  Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid.

Authors:  M D Loberg; M Cooper; E Harvey; P Callery; W Faith
Journal:  J Nucl Med       Date:  1976-07       Impact factor: 10.057

  6 in total
  2 in total

1.  Association between false negative hepatobiliary scans and initial gallbladder visualization after 30 min.

Authors:  R J Hicks; M J Kelly; V Kalff
Journal:  Eur J Nucl Med       Date:  1990

2.  Comparative quantitative evaluation of hepatic clearance of diethyl-IDA and para-butyl-IDA in jaundiced and non-jaundiced patients.

Authors:  G L Tarolo; R Picozzi; B Palagi; F Cammelli
Journal:  Eur J Nucl Med       Date:  1981-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.